Knowles M - Search Results

1

A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family.

Randerson-Moor JA, Harland M, Williams S, Cuthbert-Heavens D, Sheridan E, Aveyard J, Sibley K, Whitaker L, Knowles M, Bishop JN, Bishop DT. Randerson-Moor JA, et al. Among authors: knowles m. Hum Mol Genet. 2001 Jan 1;10(1):55-62. doi: 10.1093/hmg/10.1.55. Hum Mol Genet. 2001. PMID: 11136714

2

p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer.

Williamson MP, Elder PA, Shaw ME, Devlin J, Knowles MA. Williamson MP, et al. Among authors: knowles ma. Hum Mol Genet. 1995 Sep;4(9):1569-77. doi: 10.1093/hmg/4.9.1569. Hum Mol Genet. 1995. PMID: 8541841

3

A novel candidate tumour suppressor locus at 9q32-33 in bladder cancer: localization of the candidate region within a single 840 kb YAC.

Habuchi T, Yoshida O, Knowles MA. Habuchi T, et al. Among authors: knowles ma. Hum Mol Genet. 1997 Jun;6(6):913-9. doi: 10.1093/hmg/6.6.913. Hum Mol Genet. 1997. PMID: 9175739

4

Identification of novel bladder tumour suppressor genes.

Knowles MA. Knowles MA. Electrophoresis. 1999 Feb;20(2):269-79. doi: 10.1002/(SICI)1522-2683(19990201)20:2<269::AID-ELPS269>3.0.CO;2-7. Electrophoresis. 1999. PMID: 10197433 Review.

5

Mutation of the 9q34 gene TSC1 in sporadic bladder cancer.

Hornigold N, Devlin J, Davies AM, Aveyard JS, Habuchi T, Knowles MA. Hornigold N, et al. Among authors: knowles ma. Oncogene. 1999 Apr 22;18(16):2657-61. doi: 10.1038/sj.onc.1202854. Oncogene. 1999. PMID: 10353610

6

Somatic mutation of PTEN in bladder carcinoma.

Aveyard JS, Skilleter A, Habuchi T, Knowles MA. Aveyard JS, et al. Among authors: knowles ma. Br J Cancer. 1999 May;80(5-6):904-8. doi: 10.1038/sj.bjc.6690439. Br J Cancer. 1999. PMID: 10360673 Free PMC article.

7

No evidence of germline PTEN mutations in familial prostate cancer.

Forrest MS, Edwards SM, Hamoudi RA, Dearnaley DP, Arden-Jones A, Dowe A, Murkin A, Kelly J, Teare MD, Easton DF, Knowles MA, Bishop DT, Eeles RA. Forrest MS, et al. Among authors: knowles ma. J Med Genet. 2000 Mar;37(3):210-2. doi: 10.1136/jmg.37.3.210. J Med Genet. 2000. PMID: 10777362 Free PMC article. No abstract available.

8

Redefining a critical region of LOH on 4p16.3 in bladder cancer.

Sibley K, Bell S, Knowles MA. Sibley K, et al. Among authors: knowles ma. Genes Chromosomes Cancer. 2000 Dec;29(4):378-9. doi: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1045>3.0.co;2-k. Genes Chromosomes Cancer. 2000. PMID: 11066086 No abstract available.

9

Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma.

Sibley K, Cuthbert-Heavens D, Knowles MA. Sibley K, et al. Among authors: knowles ma. Oncogene. 2001 Feb 8;20(6):686-91. doi: 10.1038/sj.onc.1204110. Oncogene. 2001. PMID: 11314002

10

Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours.

Sibley K, Stern P, Knowles MA. Sibley K, et al. Among authors: knowles ma. Oncogene. 2001 Jul 19;20(32):4416-8. doi: 10.1038/sj.onc.1204543. Oncogene. 2001. PMID: 11466624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

810 results

Search Page

Filters